The Sage Group is a leader in providing strategic transactional advice to health care companies in the pharmaceutical, drug delivery, diagnostics, medical device, life science, regenerative medicine and nutraceutical fields. We have an incisive understanding of defining and implementing strategy for optimal asset monetization in a highly competitive marketplace. We have executed numerous M&A and licensing deals on both buy and sell side over more than 28years. We have global operations in USA, Europe, Israel, China and Japan. The Sage Group has operated globally for over 28 years. We have served clients in Pharmaceuticals, Diagnostics, Medical Technology, Nutraceuticals and Regenerative Medicine. Sage offers its clients strategic advisory services in respect of licensing, partnering and M&A – both sellside and buyside.. We can provide a full range of services for our clients to grow their businesses through strategic partnering with large, medium and small businesses in the healthcare sector. This can include financial institutions with strategic investment objectives who seek to buy and build new bioscience entities. .